Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Cytokine-cytokine receptor interaction
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬1. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Cytokine-cytokine receptor interaction
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬2. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Cytokine-cytokine receptor interaction
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Cytokine-cytokine receptor interaction
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬4. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Endocytosis 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Endocytosis
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬5. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Endocytosis 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Endocytosis
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬6. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Endocytosis 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Endocytosis
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Endocytosis 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Endocytosis
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬8. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Hematopoietic cell lineage
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬9. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Hematopoietic cell lineage
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬10. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Hematopoietic cell lineage
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Hematopoietic cell lineage
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬12. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Human T-cell leukemia virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Human T-cell leukemia virus 1 infection
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬13. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Human T-cell leukemia virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Human T-cell leukemia virus 1 infection
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬14. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Human T-cell leukemia virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Human T-cell leukemia virus 1 infection
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Human T-cell leukemia virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Human T-cell leukemia virus 1 infection
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬16. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬JAK-STAT signaling pathway
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬17. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬JAK-STAT signaling pathway
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬18. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬JAK-STAT signaling pathway
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬JAK-STAT signaling pathway
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬20. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Measles 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Measles
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬21. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Measles 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Measles
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬22. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Measles 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Measles
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Measles 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Measles
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬24. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Pathways in cancer
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬25. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Pathways in cancer
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬26. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Pathways in cancer
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Pathways in cancer
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬28. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | PI3K-Akt signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬PI3K-Akt signaling pathway
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬29. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | PI3K-Akt signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬PI3K-Akt signaling pathway
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬30. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | PI3K-Akt signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬PI3K-Akt signaling pathway
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | PI3K-Akt signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬PI3K-Akt signaling pathway
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬32. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Th1 and Th2 cell differentiation
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬33. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Th1 and Th2 cell differentiation
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬34. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Th1 and Th2 cell differentiation
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Th1 and Th2 cell differentiation
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬36. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Th17 cell differentiation
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬37. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Th17 cell differentiation
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬38. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Th17 cell differentiation
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Th17 cell differentiation
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬40. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Viral protein interaction with cytokine and cytokine receptor
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬41. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Viral protein interaction with cytokine and cytokine receptor
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬42. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Viral protein interaction with cytokine and cytokine receptor
| Basiliximab | 002 5件: 2 , 50, 97, 222, 228 💬43. Viral protein interaction with cytokine and cytokine receptor |
||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA 1件: IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬44. Viral protein interaction with cytokine and cytokine receptor
|
Cytokine-cytokine receptor interaction
1 gene, 4 drugs (DrugBank) and 21 diseases
Endocytosis
1 gene, 4 drugs (DrugBank) and 21 diseases
Hematopoietic cell lineage
1 gene, 4 drugs (DrugBank) and 21 diseases
Human T-cell leukemia virus 1 infection
1 gene, 4 drugs (DrugBank) and 21 diseases
JAK-STAT signaling pathway
1 gene, 4 drugs (DrugBank) and 21 diseases
Measles
1 gene, 4 drugs (DrugBank) and 21 diseases
Pathways in cancer
1 gene, 4 drugs (DrugBank) and 21 diseases
PI3K-Akt signaling pathway
1 gene, 4 drugs (DrugBank) and 21 diseases
Th1 and Th2 cell differentiation
1 gene, 4 drugs (DrugBank) and 21 diseases
Th17 cell differentiation
1 gene, 4 drugs (DrugBank) and 21 diseases
Viral protein interaction with cytokine and cytokine receptor
1 gene, 4 drugs (DrugBank) and 21 diseases